QVT Financial’s Zura Bio ZURA Stock Holding History

QVT Financial’s Portfolio ZURA Stock Details ZURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.2M	Buy	1,895,153 +584,560	+45%	+$2.78M	0.66%	23
2026 Q1	$7.8M	Buy	+1,310,593	New	+$7.92M	0.57%	26

Other funds holding ZURA

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

QVT Financial's ZURA Position: Q2 2026 in Review

QVT Financial increased its Zura Bio (ZURA) stake by 45% in Q2 2026, buying an estimated $2.78M and bringing the position to 1,895,153 shares worth $11.2M. The position accounts for 0.66% of the portfolio, ranked #23.

QVT Financial first reported a position in ZURA in Q1 2026 and has held it in 2 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

QVT Financial held 1,895,153 shares of Zura Bio worth $11.2M as of Q2 2026.
QVT Financial bought 584,560 Zura Bio shares in Q2 2026, an estimated $2.78M.
Zura Bio made up 0.66% of QVT Financial's portfolio in Q2 2026, its #23 holding.
QVT Financial first reported a position in Zura Bio in Q1 2026 and has held it in 2 quarters since.
95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on QVT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.